株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の血漿市場

Global Blood Plasma Market Report: 2016 Edition

発行 Koncept Analytics 商品コード 233439
出版日 ページ情報 英文 57 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
世界の血漿市場 Global Blood Plasma Market Report: 2016 Edition
出版日: 2016年06月27日 ページ情報: 英文 57 Pages
概要

当レポートでは、世界の血漿市場について調査分析し、主要な地域市場に焦点を当てて、主要動向や発展、課題、競合情勢、主要企業プロファイルなど、体系的な情報を提供しています。

第1章 概要

  • 血漿の成分
  • 血漿の機能
  • 血漿の収集・抽出

第2章 世界の市場分析

  • 世界の血漿市場
  • 世界の免疫グロブリン (Ig) 市場
  • 世界のアルブミン市場
  • 世界の血漿由来第VIII因子市場
  • 世界のA1PI市場

第3章 米国の血漿市場

  • 米国の血漿分画能力
  • 米国の血液製剤の利用:カテゴリー別
  • 米国の免疫グロブリン (Ig) 市場

第4章 中国の血漿市場

  • 中国の血漿市場収益
  • 中国の血漿の収集量
  • 中国の血漿の生産量
  • 中国のヒトアルブミン市場収益
  • 中国の免疫グロブリン (Ig) 市場収益

第5章 市場力学

  • 成長促進要因
  • 主要動向
  • 課題

第6章 競合情勢

  • 競合:市場シェア別
  • 競合:時価総額別

第7章 企業プロファイル

  • Grifols
  • Baxter International Inc
  • CSL Limited
  • Octapharma AG

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The raw material for blood plasma industry is the liquid that is a component of blood called blood plasma. Blood plasma makes up approximately 55% of the total blood volume. Blood plasma is pale yellow in color and consists of water, proteins and salt. Those proteins are used to produce medicinal products for treatment of a variety of life-threatening diseases, illnesses and conditions. These plasma-derived medications are the standard course of treatment for thousands of people, in more than 100 countries across the globe, who need the treatment to improve their health and lead productive lives.

The chief components of the global blood plasma market are immunoglobulin, albumin, factor VIII and Alpha-1 proteinase inhibitor (A1PI) or alpha-1 antitrypsin (AAT). These components are proteins and antibodies that are extracted from the fractionated blood plasma and used for the treatment of various indications.

The key factors which are anticipated to drive this market include rising healthcare expenditure, growing demand for polyvalent immunoglobulin and increasing market for albumin in the Asia-pacific. Some of the noteworthy progresses of this industry include the new potential for raising AATD diagnosis and introduction of extended half-life products for hemophilia. However, the growth of respective industry is challenged by the high cost of production that discourages new entrants, shrinking market for plasma-derived factor VIII, high industry regulation in the emerging market and increasing threat of substitutes.

The report provides a wide-ranging study of global blood plasma market and also major regional markets. Furthermore, market dynamics such as key trends and development; and challenges are examined in depth. The global blood plasma market is highly competitive consisting of several large conglomerates including Baxter international, CSL, Grifols, Octapharma etc. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.

Table of Contents

1. Overview

  • 1.1 Components of Blood Plasma
    • 1.1.1 Proteins
    • 1.1.2 Amino Acids
    • 1.1.3 Electrolytes
    • 1.1.4 Nutrients
    • 1.1.5 Gases
    • 1.1.6 Nitrogenous Waste
  • 1.2 Functions of Blood Plasma
    • 1.2.1 Carry Nutrients
    • 1.2.2 Maintain Equilibrium of Electrolytes
    • 1.2.3 Sustain Blood Volume
    • 1.2.4 Safeguard the Body
    • 1.2.5 Removal of Waste
  • 1.3 Collection and Extraction of Plasma
    • 1.3.1 Plasma Collection
    • 1.3.2 Plasma Extraction
    • 1.3.3 Plasma Fractionation Yield
    • 1.3.4 Plasma Usage

2. Global Market Analysis

  • 2.1 Global Blood Plasma Market
    • 2.1.1 Global Blood Plasma Market Revenue
    • 2.1.2 Global Blood Plasma Market by Category
    • 2.1.3 Global Blood Derivative Drugs Market by Region - Value
    • 2.1.4 Global Blood Derivative Drugs Market by Patient Count
  • 2.2 Global Immunoglobulin Market
    • 2.2.1 Global Immunoglobulin Market Revenue
    • 2.2.2 Global Intravenous and Subcutaneous Immunoglobulin Demand
  • 2.3 Global Albumin Market
    • 2.3.1 Global Albumin Market Revenue
    • 2.3.2 Global Albumin Market by Volume
  • 2.4 Global Plasma-Derived Factor VIII Market
    • 2.4.1 Global Factor VIII Market Revenue by Category
    • 2.4.2 Global Plasma-Derived Factor VIII Revenue
  • 2.5 Global A1PI Market
    • 2.5.1 Global A1PI Market Revenue
    • 2.5.2 Global AATD Patient Count

3. The US Blood Plasma Market

  • 3.1 The US Plasma Fractionation Capacity
  • 3.2 The US Blood Derivative Usage by Category
  • 3.3 The US Immunoglobulin Market
    • 3.3.1 The US Immunoglobulin Market Revenue
    • 3.3.2 The US Immunoglobulin Market by Volume
    • 3.3.3 The US Immunoglobulin Market Volume by Category
    • 3.3.4 The US Intravenous Immunoglobulin (IVIG) Market by Volume
    • 3.3.5 The US Subcutaneous Immunoglobulin (SCIG) Market by Volume
    • 3.3.6 The US IV/SCIG Market by Medical Specialty

4. China Blood Plasma Market

  • 4.1 China Blood Plasma Market Revenue
  • 4.2 China Blood Plasma Collection Volume
  • 4.3 China Blood Plasma Output Volume
  • 4.4 China Human Albumin Market Revenue
  • 4.5 China Immunoglobulin Market Revenue

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Growing Demand for Polyvalent Immunoglobulin
    • 5.1.2 Increasing Market for Albumin in the Asia-Pacific
    • 5.1.3 Rising Healthcare Expenditure
  • 5.2 Key Trends
    • 5.2.1 New Potential for Raising AATD Diagnosis
    • 5.2.2 Introduction of Extended Half-Life Products for Hemophilia
  • 5.3 Challenges
    • 5.3.1 High Cost of Production Discourages New Entrants
    • 5.3.2 Shrinking Market for Plasma-Derived Factor VIII
    • 5.3.3 High Industry Regulations in Emerging Market - China
    • 5.3.4 Increasing Threat of Substitutes

6. Competitive Landscape

  • 6.1 Competition by Market Share
    • 6.1.1 Global Blood Derivative Drugs Market Share
    • 6.1.2 Global IVIG Market Share
    • 6.1.3 Global AAT Market Share
    • 6.1.4 The US Plasma Protein Market Share
  • 6.2 Competition by Market Capitalization

7. Company Profiles

  • 7.1 Grifols
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Baxter International Inc
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 CSL Limited
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Octapharma AG
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies

List of Charts

  • Plasma Extraction from Donated Blood (Recovered Plasma)
  • Plasmapheresis (Sourced Plasma)
  • Global Blood Plasma Market Revenue (2013-2018F)
  • Global Blood Plasma Market by Category (2015)
  • Global Blood Derivative Drugs Market by Region - Value (2015)
  • Global Blood Derivative Drugs Market by Patient Count (2015)
  • Global Immunoglobulin Market Revenue (2013-2018F)
  • Global Intravenous and Subcutaneous Immunoglobulin Demand (2010-2015E)
  • Global Albumin Market Revenue (2013-2018F)
  • Global Albumin Market by Volume (2010-2020F)
  • Global Factor VIII Market Revenue by Category (2015)
  • Global Plasma-Derived Factor VIII Revenue (2013-2018F)
  • Global A1PI Market Revenue (2013-2018F)
  • Global AATD Patient Count (2014-2020)
  • The US Plasma Fractionation Capacity - Actuals (2012-2015E)
  • The US Plasma Fractionation Capacity - Forecast (2016F-2020F)
  • The US Blood Derivative Usage by Category (2015)
  • The US Immunoglobulin Market Revenue (2013-2018F)
  • The US Immunoglobulin Market by Volume (2013-2020F)
  • The US Immunoglobulin Market Volume by Category (2015)
  • The US Intravenous Immunoglobulin (IVIG) Market by Volume (2013-2020F)
  • The US Subcutaneous Immunoglobulin (SCIG) Market by Volume (2013-2020F)
  • The US IV/SCIG Market by Medical Specialty (2016F)
  • China Blood Plasma Market Revenue (2014-2020F)
  • China Blood Plasma Collection Volume (2008-2015E)
  • China Blood Plasma Output Volume (2012-2015E)
  • China Human Albumin Market Revenue (2013-2020F)
  • China Immunoglobulin Market Revenue (2014-2020F)
  • Global Demand for Polyvalent Immunoglobulin (2008-2020F)
  • Asia-Pacific Albumin Market by Volume (2010-2020F)
  • Global Healthcare Expenditure (2010-2015E)
  • Global Blood Derivative Drugs Market Share (2015)
  • Global IVIG Market Share (2015)
  • Global AAT Market Share (2015)
  • The US Plasma Protein Market Share (2015)
  • Market Cap Comparison of Key Players (2015)
  • Revenue Share by Business Segments, Grifols (2015)
  • Revenue and Net Income, Grifols (2011-2015)
  • Revenue Share by Business Segments, Baxter International Inc (2015)
  • Revenue and Net Income, Baxter International Inc (2013-2015)
  • Revenue Share by Business Segments (2015)
  • Revenue and Net Income, CSL Limited (2011-2015)
  • Revenue and Net Income, Octapharma AG (2011-2015)

List of Tables

  • Clinical Uses of Plasma Proteins
  • Recovered Plasma vs. Sourced Plasma
  • Output per Liter of Plasma
  • Extended Half-Life Products under Development (2015)
Back to Top